Comparison of Two Marketed Lenses in a Controlled Environment

Inclusion criteria

• The subject must be 18 years of age and less than 51 years of age;
• The subject must have read and understood the Participant Information Sheet;
• The subject must have read, signed and dated the Informed Consent;
• The subject must be a current planned replacement soft contact lens wearer;
• The subject must be a regular user of devices (computer, tablet and/or smart phone) for a minimum average of 5 ± 1 hours per day in a typical week
• The subject must have a refractive error within the range of correction of both study contact lenses;
• The subject must have a best-corrected visual acuity of 6/9 (20/30, 0.18 LogMAR) or better in each eye;
• The subject must demonstrate an acceptable fit with both study contact lenses;
• The subject must agree to wear their contact lenses as directed for the duration of the study (every day or for at least a minimum of five days per week for a minimum of six hours per day and be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule;
• The subject must have normal eyes with the exception of the need for visual correction.

Exclusion criteria

• Any known sensitivity or intolerance to any of the contact lenses or adjunct products to be used.
• Monocular vision (only one eye with functional vision or only one eye fitted with contact lenses).
• Use of systemic or ocular concomitant medications which, as determined by the investigator, might contraindicate or interfere with contact lens wear.
• Ocular anterior segment infection, inflammation, abnormality, or active disease, which would contraindicate contact lens wear.
• Any moderate or severe ocular condition observed during slit lamp examination at the enrollment visit.
• A history of herpetic keratitis, ocular surgery or irregular cornea(s).
• Known pregnancy or lactation during the study period.
• Enrollment of investigator's office staff, relatives, or members of their respective households.
• Participation in any clinical trial within 30 days of the enrollment visit.